380 related articles for article (PubMed ID: 20729866)
1. Advanced antisense therapies for postexposure protection against lethal filovirus infections.
Warren TK; Warfield KL; Wells J; Swenson DL; Donner KS; Van Tongeren SA; Garza NL; Dong L; Mourich DV; Crumley S; Nichols DK; Iversen PL; Bavari S
Nat Med; 2010 Sep; 16(9):991-4. PubMed ID: 20729866
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
3. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
4. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
5. Vaccine research efforts for filoviruses.
Hart MK
Int J Parasitol; 2003 May; 33(5-6):583-95. PubMed ID: 12782057
[TBL] [Abstract][Full Text] [Related]
6. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
Swenson DL; Wang D; Luo M; Warfield KL; Woraratanadharm J; Holman DH; Dong JY; Pratt WD
Clin Vaccine Immunol; 2008 Mar; 15(3):460-7. PubMed ID: 18216185
[TBL] [Abstract][Full Text] [Related]
7. Ebola and Marburg virus vaccines.
Reynolds P; Marzi A
Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
[TBL] [Abstract][Full Text] [Related]
8. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.
Lever MS; Piercy TJ; Steward JA; Eastaugh L; Smither SJ; Taylor C; Salguero FJ; Phillpotts RJ
J Med Microbiol; 2012 Jan; 61(Pt 1):8-15. PubMed ID: 21852521
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
Geisbert TW; Daddario-Dicaprio KM; Geisbert JB; Reed DS; Feldmann F; Grolla A; Ströher U; Fritz EA; Hensley LE; Jones SM; Feldmann H
Vaccine; 2008 Dec; 26(52):6894-900. PubMed ID: 18930776
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
Geisbert TW; Feldmann H
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
[TBL] [Abstract][Full Text] [Related]
11. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
Geisbert TW; Strong JE; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
[TBL] [Abstract][Full Text] [Related]
12. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
Warren TK; Wells J; Panchal RG; Stuthman KS; Garza NL; Van Tongeren SA; Dong L; Retterer CJ; Eaton BP; Pegoraro G; Honnold S; Bantia S; Kotian P; Chen X; Taubenheim BR; Welch LS; Minning DM; Babu YS; Sheridan WP; Bavari S
Nature; 2014 Apr; 508(7496):402-5. PubMed ID: 24590073
[TBL] [Abstract][Full Text] [Related]
13. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R
PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200
[TBL] [Abstract][Full Text] [Related]
14. Prospects for immunisation against Marburg and Ebola viruses.
Geisbert TW; Bausch DG; Feldmann H
Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
[TBL] [Abstract][Full Text] [Related]
15. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines.
Marzi A; Kercher L; Marceau J; York A; Callsion J; Gardner DJ; Geisbert TW; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S404-9. PubMed ID: 26022440
[TBL] [Abstract][Full Text] [Related]
16. Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays.
Kamata T; Natesan M; Warfield K; Aman MJ; Ulrich RG
Clin Vaccine Immunol; 2014 Dec; 21(12):1605-12. PubMed ID: 25230936
[TBL] [Abstract][Full Text] [Related]
17. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
Leroy E; Baize S; Gonzalez JP
Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
[TBL] [Abstract][Full Text] [Related]
18. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.
Dye JM; Herbert AS; Kuehne AI; Barth JF; Muhammad MA; Zak SE; Ortiz RA; Prugar LI; Pratt WD
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5034-9. PubMed ID: 22411795
[TBL] [Abstract][Full Text] [Related]
19. Progress in filovirus vaccine development: evaluating the potential for clinical use.
Falzarano D; Geisbert TW; Feldmann H
Expert Rev Vaccines; 2011 Jan; 10(1):63-77. PubMed ID: 21162622
[TBL] [Abstract][Full Text] [Related]
20. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge.
Grant-Klein RJ; Van Deusen NM; Badger CV; Hannaman D; Dupuy LC; Schmaljohn CS
Hum Vaccin Immunother; 2012 Nov; 8(11):1703-6. PubMed ID: 22922764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]